Skip to main content
Content for healthcare professionals only
Radcliffe Group
Cardiology
Vascular
CVRM
Medical Education
Register for FREE
Log In
View all Platforms
Cardiology
Topics
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
Events
Upcoming Events
Radcliffe Events
All Events
Resource Hubs
Empagliflozin in the Treatment of Chronic Heart Failure
Pulmonary Embolism
Pulsed Field Ablation
Radcliffe Platforms
Radcliffe Group
Cardiology
Vascular
CVRM
Medical Education
Register for FREE
Log In
Content for healthcare professionals only
Topics
Featured
Advancement in Heart Failure
Amyloidosis
Cardiomyopathy
Cardio-oncology
Diabetes
Hypertension Management
Nonalcoholic Steatohepatitis (NASH)
Obesity
Pulmonary Embolism
Stroke Prevention in Atrial Fibrillation
Sudden Cardiac Death
Anticoagulation
COVID-19
CV Disease in Special Populations
Demographic
Digital Health
Electrophysiology & Arrhythmia
Heart Failure
Heterogeneous Populations
Imaging & Diagnostics
Intervention
MI / ACS
Pericardium Disorders
Prevention & Chronic Conditions
Standards & Guidelines
Vascular Disease & Surgery
Content Type
Videos
Articles
Journals
Broadcasts
Education
Podcasts
News
Journals
AER
CFR
ECR
ICR3
JAPSC
USC
Faculty
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
View All
Juan Carlos Kaski
Peter O'Kane
Ankur Kalra
Angelo Auricchio
Harriette Van Spall
Andrew Coats
Mirvat Alasnag
Arjun Ghosh
Demos Katritsis
Nicolas Van Mieghem
Joost Daemen
Carolyn Lam
Events
Upcoming Events
Radcliffe Events
All Events
Resource Hubs
Empagliflozin in the Treatment of Chronic Heart Failure
Pulmonary Embolism
Pulsed Field Ablation
Breadcrumb
Home /
News Index
Latest News
REVERSE II TRIAL DECISION RULE HELPS IDENTIFY WOMEN WHO CAN SAFELY DISCONTINUE ANTICOAGULANTS
30 August 2016
Caution urged in the use of blood pressure lowering treatment for heart disease patients
30 August 2016
BASKET-SAVAGE TRIAL DRUG ELUTING STENTS MORE BENEFIT IN SAPHENOUS VEIN GRAFTS
30 August 2016
NORSTENT TRIAL LESS EFFICACY THAN EXPECTED IN LARGEST DRUG-ELUTING STENT TRIAL
30 August 2016
MULTIPLICATIVE” BENEFIT OF CHOLESTEROL AND BLOOD PRESSURE-LOWERING ON CARDIOVASCULAR RISK
29 August 2016
ODYSSEY ESCAPE - ALIROCUMAB CUTS APHERESIS RATES IN FAMILIAL HYPERCHOLESTEROLEMIA
29 August 2016
LIPOPROTEIN APHERESIS: A NEW APPROACH TO REFRACTORY ANGINA?
29 August 2016
GARFIELD-AF Score substantially superior to CHA2DS2-VASc
29 August 2016
First European standards for management of heart attack patients launched today
29 August 2016
NO OVERALL SURVIVAL BENEFIT WITH ICDS IN NON-ISCHEMIC HEART FAILURE
28 August 2016
Load More
External news
Written by:
Medscape
AI Ethics in Personalized Medicine: Key Insights for Doctors
15 October 2024
Written by:
Medscape
AI's Real-World Impact: Clinical Decision Support
15 October 2024
Written by:
Medscape
AI-Repurposed Drugs: Essential Considerations for Physicians
15 October 2024
Written by:
Medscape
Infographic: Cognitive Tests for Older Docs?
15 October 2024
Written by:
Medscape
Does Mast Cell Activation Syndrome Underlie Multiple Ills?
15 October 2024
Written by:
Cardiac Vascular News
NKGen Biotech Announces Upcoming Presentation at the 16th World Stroke Congress (WSC 2024)
15 October 2024
Written by:
Cardiac Vascular News
Inari Medical Announces Partnership with AVF and NBCA on DEFIANCE Trial
15 October 2024
Written by:
Cardiac Vascular News
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
15 October 2024
Written by:
Medscape
Combo of Gout Genetics and Poor Lifestyle Can Up CVD Risk
15 October 2024
Written by:
Cardiac Vascular News
InspireMD Announces Establishment of Global Headquarters in Miami, Florida to Support Anticipated U.S. Launch and Commercialization of the CGuard Prime Carotid Stent System
15 October 2024
Load More